Search
+

    Indian engineer develops rapidly producible Covid-19 ventilators

    Synopsis

    Citadel Research and Solutions has developed cost-effective ventilators that were tested successfully by healthcare professionals on the patients. Citadel produced prototype ventilators using precision air pumps for both high-end and low-end variants and has filed for patents for design and innovation

    ETtech
    Coronavirus

    COVID-19 CASES

    Confirmed
    2,396,637
    Deaths
    47,033
    An Indian engineer with experience in biomedical and aerospace electronics, who had headed the digital healthcare arms of General Electric and Wipro, claims to have developed rapidly producible ventilators for Covid-19 patients meeting the global standards prescribed by developed economies.

    Konda Vishweshwar Reddy, who is also the lone Indian to have received US patents while being in the office as a Parliamentarian, said his firm Citadel Research and Solutions has developed cost-effective ventilators that were tested successfully by healthcare professionals on the patients.

    Reddy’s firm, which had earlier sold many intellectual property rights to global giants like GE and Wipro, is now in talks with a few global and domestic healthcare equipment makers who evinced interest in the collaborative production of ventilators titled ‘ICoVent ventilators’.

    Citadel produced prototype ventilators using precision air pumps for both high-end and low-end variants and has filed for patents for design and innovation, said Reddy. “These ventilators, produced using indigenous components without depending on advanced imported sensors and regulators, meet all the specifications fixed by the UK and Canadian governments as well as those of the Indian government’s empowered committee,” he told ET.

    After completing the functional testing, Citadel has tested its ventilators on an imported Ventilator Testing Calibration Validation and Certification machine in the absence of any certification agency for the healthcare equipment.

    The company is also sharing results live with an international team of peer reviewers, medical professionals and engineers, apart from the Indian government empowered committee.

    “Now the reliability, repeatability and robustness tests have started to run the ventilators continuously for two weeks nonstop without failing,” said Reddy, hoping to commence commercial scale manufacturing in couple of weeks to rollout the product into the market in 3-4 weeks.

    The R&D centre-cum-production facility of Citadel in Hyderabad is capable of producing 200-300 units a month of these patent-pending precision air pump ventilators at costs ranging from Rs 40,000-Rs 1.2 lakh a unit for low to high-end variants, as compared with Rs 5-20 lakh a unit for similar range being produced by the global ICU ventilator manufacturers.
    (Catch all the Business News, Breaking News Events and Latest News Updates on The Economic Times.)

    3 Comments on this Story

    Rohit Joshi114 days ago
    Well done !!! But things take a lot of time to move in India. Wonder what happenned to the ventilators promised by so many of our industrialists ? The air ionisers that could disinfect large areas in a few seconds ?
    Yash Vora114 days ago
    well done - now ramp up to make use of economy of quantity
    Sridhar Ramarao114 days ago
    Congratulations Sir. Please make sure our requirements are fully met before exports. God bless.
    The Economic Times